A Glimpse into Research at Johns Hopkins University
Introduction: What is IV Mistletoe Therapy?
Mistletoe, a semi-parasitic plant with a long history of traditional use, has recently gained attention for its potential therapeutic benefits in cancer treatment. Researchers at the renowned Johns Hopkins Kimmel Cancer Center conducted a groundbreaking phase I trial on intravenous mistletoe extract, Helixor M, in the United States. This trial aimed not only to evaluate the safety of mistletoe extract but also to explore its impact on the quality of life and disease control in patients with advanced and treatment-resistant cancers.